BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/7/2017 6:18:45 AM | Browse: 56 | Download: 24
Publication Name World Journal of Hepatology
Manuscript ID 32952
Country of Manuscript Source Greece
Received
2017-02-01 13:57
Peer-Review Started
2017-02-08 14:24
To Make the First Decision
2017-05-23 00:50
Return for Revision
2017-06-12 01:30
Revised
2017-07-18 08:04
Second Decision
2017-08-11 07:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-08-16 17:54
Articles in Press
2017-08-16 17:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-09-05 02:37
Publish the Manuscript Online
2017-09-07 02:39
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Hepatitis B in renal transplant patients
Manuscript Source Invited Manuscript
All Author List Smaragdi Marinaki, Kyriaki Kolovou, Stratigoula Sakellariou, John N Boletis and Ioanna K Delladetsima
Funding Agency and Grant Number
Correspondence To Ioanna K Delladetsima, PhD, Professor, First Department of Pathology, Medical School, University of Athens, Mikras Asia 75, Goudi, Athens 11527, Greece. idelladet@med.uoa.gr
Keywords Hepatitis B virus (+) donor; Hepatitis B virus (+) recipient; Renal transplantation; Viral reactivation; Immunosuppression; Nucleoside analogues; Antiviral discontinuation; Antiviral prophylaxis; Hepatitis B
Core Tip Though decreasing, hepatitis B still remains a considerable problem, especially in high-risk patient populations as kidney transplant recipients. The widespread use of new antivirals and the introduction of universal prophylaxis immediately after transplantation have changed the picture in hepatitis B virus (HBV) (+) transplantation. Long term survival rates of HBV(+) recipients are approaching those of HBV(-), altering HBV(+) kidney transplantation from a “high risk” procedure into routine practice. Furthermore, accumulating evidence confirms the safety of trans­plantation from HBsAg(+) donors into immunized recipients. All immunosuppressants can be used in HBV(+) transplantation and total immunosuppression must be kept at the lowest possible levels long term.
Publish Date 2017-09-07 02:39
Citation Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK. Hepatitis B in renal transplant patients. World J Hepatol 2017; 9(25): 1054-1063
Url http://www.wjgnet.com/1948-5182/full/v9/i25/1054.htm
DOI http://dx.doi.org/10.4254/wjh.v9.i25.1054
Full Article (PDF) WJH-9-1054.pdf
Full Article (Word) WJH-9-1054.doc
Revised Manuscript 32952-Review.doc
Peer-review Report 32952-Peer-review(s).pdf
Answering Reviewers 32952-Answering reviewers.pdf
Scientific Misconduct Check 32952-Scientific misconduct check.pdf
Scientific Editor Work List 32952-Scientific editor work list.pdf
Audio Core Tip 32952-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 32952-Conflict-of-interest statement.pdf
Copyright License Agreement 32952-Copyright assignment.pdf